EUCTR2008-002310-22-IT进行中（未招募）不适用
A multicenter phase II trial of Recipient pre-treatment with Short-Term Rapamycin for the prevention of acute GVHD after hematopoietic stem cell transplantation in Elderly Patients - ND
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI0 个研究点开始时间: 2008年6月25日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Signed informed consent
- •Age > 55 years
- •Bone Marrow or PBSC graft
- •HLA-identical or 1 antigen-mismatched donor
- •Early disease (non neoplastic disease, AML or ALL in 1st complete remission, CML in 1st chronic phase, chemosensitive Lymphoma or Myeloma)
- •Reduced Intensity Conditioning (RIC) regimen
- •Normal renal or hepatic function
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Unable to sign informed consent
- •Age <50 years
- •Cord Blood grafts
- •>1 HLA antigen mismatched donor
- •Advanced disease (based on above definitions of early disease)
- •Myeloablative conditioning
- •Renal failure (creatinine > 2 mg/dL or creatinine clearance <60 ml/24 hrs)
- •Altered hepatic function (AT > 5 times normal or bilirubin > 3 mg/dL)
- •HBV, HCV or HIV infection
研究者
相似试验
已完成
2 期
A multicenter randomized phase II/III trial of preoperative versus postoperative chemotherapy with XELOX plus bevacizumab in patients with resectable colorectal liver metastasis.Resectable liver metastasis from colorectal cancerJPRN-UMIN000003783Hiroshima Surgical study group of Clinical Oncology81
已完成
2 期
A multicenter phase II study for previouly untreated advanced stage peripheral T-cell lymphoma evaluating efficacy and safety of combination chemotherapy with THP-COP regimepreviouly untreated advanced stage peripheral T-cell lymphomaJPRN-UMIN000014902Hematological Malignancy Study Group40
进行中（未招募）
1 期
A prospective phase II, randomized multi-center trial of a combined modularized treatment with metronomic low-dose treosulfan, pioglitazone and clarithromycin versus nivolumab in patients with squamous cell lung cancer and non- squamous cell lung cancer, respectively after platin failure (ModuLung)EUCTR2014-004095-31-DEFreistaat Bayer respresented by University of Regensburg represented by Kaufmännischer Direktor86
进行中（未招募）
不适用
A multicenter phase II clinical trial assessing the efficacy of the combination of lapatinib and capecitabine in patients with non pretreated brain metastasis from HER2 positive breast cancer. - LANDSCAPEEUCTR2008-001084-10-FRFNCLCC
招募中
不适用
The Clinical Trial of Low Dose Irradiation for Alzheimer's DiseaseDiseases of the nervous systemKCT0007550Kyung Hee University Hospital at Gangdong60